IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
66 hedge funds and large institutions have $63.5M invested in Insight Molecular Diagnostics Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
66
Holders Change
+10
Holders Change %
+17.86%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
28
Reduced
12
Closed
5
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$1K
Top Buyers
1 |
BC
1
Blackcrane Capital
Bellevue,
Washington
|
$5.7M |
2 |
BC
2
Broadwood Capital
New York
|
$28.1M |
3 |
3
BlackRock
New York
|
$4.96M |
4 |
PVI
4
Pura Vida Investments
New York
|
$11.4M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$3.46M |